We are extremely proud to announce Orthoplastics has been awarded our first Queen’s Awards for Enterprise and International trade.
Orthoplastics is a fully dedicated end-to-end solution provider to the medical sector and has developed an international presence with over 350 global OEM’s producing implantable orthopaedic products.
Orthoplastics’ expert knowledge of orthopaedic materials has been developed continuously and our vision of becoming the industry’s leading manufacturer of medical-grade plastics has been achieved through our unsurpassed dedication to quality and excellence.
Investing both time and resources into developing our knowledge of medical plastics and advanced manufacturing techniques has enabled us to continually surpass our customers exacting standards.
Science making a material difference
Our products were initially pioneered in the UK around 1969 for orthopaedic applications and have over 50 years of successful clinical history throughout the world.
Orthoplastics has been supplying materials for life-changing surgeries since 1996 and has led the way in making recognisable contributions to joint replacement. Our motto ‘science making a material difference’ truly promises an extended product life span and a greatly improved quality of life for patients that receive orthopaedic implants.
In recent years, orthopaedic device manufacturers have identified UHMWPE as the most suitable orthopaedic material to use when creating medical-grade applications for the health sector.
Orthoplastics have drawn upon its industry expertise in medical plastics to provide a series of integrated processes to produce the highest quality of UHMWPE in the world. It’s this premium-grade product that is now the material of choice for orthopaedic device manufacturers across the globe.
Its advanced industry knowledge provides Orthoplastics with the opportunity to continually develop and manufacture innovative product solutions for the medical industry.
An outstanding achievement
We are extremely proud to be awarded our first Queen’s Awards for Enterprise and International trade. The award was confirmed on Tuesday 21st April and is an outstanding achievement for the whole team.
Managing Director Mark Allen says
“winning such a prestigious award confirms that Orthoplastics is a leader in the manufacture of medical-grade plastics for the medical sector. The Queen’s Award for Enterprise is the highest accolade for British businesses, bringing with it a host of new opportunities and recognition nationally and internationally.”
The Queen’s Awards for Enterprise are the most prestigious business awards in the UK. The awards were first established in 1965 and since then over 7000 companies have achieved a Queen’s Awards.
The awards celebrate the success of exciting and innovative businesses which are leading the way with pioneering products or services, delivering impressive social mobility programmes or showing their commitment to excellent sustainable development practices.
We are uniquely placed to service global providers with not just materials, but semi-finished devices manufactured in a highly regulated environment using bespoke process techniques. As part of the ‘Viant Inc’ group, our depth of knowledge and capabilities will enhance patients’ lives forever.